SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-154688
Filing Date
2015-04-29
Accepted
2015-04-29 09:07:36
Documents
8
Effectiveness Date
2015-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d911674ddefa14a.htm DEFA14A 34906
2 GRAPHIC g911674na_pg001.jpg GRAPHIC 1318
3 GRAPHIC g911674na_pg002a.jpg GRAPHIC 2204
4 GRAPHIC g911674na_pg002b.jpg GRAPHIC 2245
5 GRAPHIC g911674na_pg002c.jpg GRAPHIC 2339
6 GRAPHIC g911674na_pg002d.jpg GRAPHIC 1426
7 GRAPHIC g911674na_pg003.jpg GRAPHIC 1438
8 GRAPHIC g911674na_pg004.jpg GRAPHIC 1320
  Complete submission text file 0001193125-15-154688.txt   53931
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36287 | Film No.: 15810296
SIC: 2834 Pharmaceutical Preparations